Table of Contents List of Tables List of Figures Introduction Global Markets Direct Report Coverage Iron Deficiency Anemia - Overview Iron Deficiency Anemia - Therapeutics Development Pipeline Overview Pipeline by Companies Pipeline by Universities/Institutes Products under Development by Companies Products under Development by Universities/Institutes Iron Deficiency Anemia - Therapeutics Assessment Assessment by Target Assessment by Mechanism of Action Assessment by Route of Administration Assessment by Molecule Type Iron Deficiency Anemia - Companies Involved in Therapeutics Development Akebia Therapeutics Inc Galenica Ltd Novartis AG Panion & Bf Biotech Inc Pharmacosmos AS Pieris Pharmaceuticals Inc Rockwell Medical Inc Shield Therapeutics Plc Iron Deficiency Anemia - Drug Profiles AKB-5343 - Drug Profile Product Description Mechanism Of Action R&D Progress CSJ-137 - Drug Profile Product Description Mechanism Of Action R&D Progress Drug to Replace Iron for Iron Deficiency Anemia - Drug Profile Product Description Mechanism Of Action R&D Progress ferric carboxymaltose - Drug Profile Product Description Mechanism Of Action R&D Progress ferric citrate - Drug Profile Product Description Mechanism Of Action R&D Progress ferric maltol - Drug Profile Product Description Mechanism Of Action R&D Progress ferric pyrophosphate citrate - Drug Profile Product Description Mechanism Of Action R&D Progress hinokitiol - Drug Profile Product Description Mechanism Of Action R&D Progress iron isomaltoside - Drug Profile Product Description Mechanism Of Action R&D Progress NSC-8679 - Drug Profile Product Description Mechanism Of Action R&D Progress Peptides to Activate Erythroferrone for Iron Deficiency Anemia - Drug Profile Product Description Mechanism Of Action R&D Progress PRS-080 - Drug Profile Product Description Mechanism Of Action R&D Progress PT-30 - Drug Profile Product Description Mechanism Of Action R&D Progress Iron Deficiency Anemia - Dormant Projects Iron Deficiency Anemia - Product Development Milestones Featured News & Press Releases Nov 07, 2017: U.S. FDA Approves Auryxia (ferric citrate) Tablets as a Treatment for People with Iron Deficiency Anemia and Chronic Kidney Disease, Not on Dialysis Nov 02, 2017: Keryx Biopharmaceuticals Announces Presentation of Post-Hoc Data From Phase 3 Study of Auryxia (Ferric Citrate) in Adults With Iron Deficiency Anemia and Non-dialysis Dependent Chronic Kidney Disease Oct 30, 2017: Rockwell Medical Announces Two Triferic Poster Presentations at American Society of Nephrology Kidney Week 2017 Annual Meeting Oct 13, 2017: Keryx Biopharmaceuticals Announces Presentations of New Data at the American Society of Nephrology Kidney Week 2017 Annual Meeting Oct 10, 2017: Shield Therapeutics: Completion of patient enrolment in pivotal AEGIS-CKD Phase 3 study Sep 06, 2017: Shield Therapeutics: US Composition of Matter Patent Jul 12, 2017: Vifor Pharma Announces Three Outcomes Trials in Heart Failure and Iron Deficiency Jun

List of Tables Number of Products under Development for Iron Deficiency Anemia, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products under Development by Universities/Institutes, H1 2018 Products under Development by Companies, H1 2018 Products under Development by Universities/Institutes, H1 2018 Number of Products by Stage and Target, H1 2018 Number of Products by Stage and Mechanism of Action, H1 2018 Number of Products by Stage and Route of Administration, H1 2018 Number of Products by Stage and Molecule Type, H1 2018 Iron Deficiency Anemia - Pipeline by Akebia Therapeutics Inc, H1 2018 Iron Deficiency Anemia - Pipeline by Galenica Ltd, H1 2018 Iron Deficiency Anemia - Pipeline by Novartis AG, H1 2018 Iron Deficiency Anemia - Pipeline by Panion & Bf Biotech Inc, H1 2018 Iron Deficiency Anemia - Pipeline by Pharmacosmos AS, H1 2018 Iron Deficiency Anemia - Pipeline by Pieris Pharmaceuticals Inc, H1 2018 Iron Deficiency Anemia - Pipeline by Rockwell Medical Inc, H1 2018 Iron Deficiency Anemia - Pipeline by Shield Therapeutics Plc, H1 2018 Iron Deficiency Anemia - Dormant Projects, H1 2018 List of Figures Number of Products under Development for Iron Deficiency Anemia, H1 2018 Number of Products under Development by Companies, H1 2018 Number of Products by Targets, H1 2018 Number of Products by Stage and Targets, H1 2018 Number of Products by Mechanism of Actions, H1 2018 Number of Products by Stage and Mechanism of Actions, H1 2018 Number of Products by Routes of Administration, H1 2018 Number of Products by Stage and Routes of Administration, H1 2018 Number of Products by Molecule Types, H1 2018 Number of Products by Stage and Molecule Types, H1 2018

Akebia Therapeutics Inc Galenica Ltd Novartis AG Panion & Bf Biotech Inc Pharmacosmos AS Pieris Pharmaceuticals Inc Rockwell Medical Inc Shield Therapeutics Plc